A major medical journal published a study this month that reported an alleged increase in deaths in patients with closed head injuries who use the blood thinner Pradaxa. The Pradaxa attorneys at RLG acknowledge the study’s results noting that excessive bleeding is among the drug’s alleged side effects the firm hears about from prospective Pradaxa plaintiffs…. Read more
The blood thinner Pradaxa which has alleged excessive bleeding side effects is now under scrutiny because of another potential risk: viral infections according to a study conducted by researchers at the University of North Carolina. The Rottenstein Law Group a Pradaxa law firm acknowledges the study and maintains its Pradaxa… Read more
On its website Boehringer Ingelheim markets blood-thinner Pradaxa as 35 percent more effective at reducing stroke than warfarin. But a recent study presented at a Joint Session of the Heart Rhythm Society and the American College of Cardiology in San Francisco indicated that Pradaxa was no better than warfarin an anticoagulant that has… Read more
Although there have been numerous Pradaxa lawsuits because of the anticoagulant drug’s alleged excessive bleeding side effects the U.S. Food and Drug Administration issued a report this week indicating that those effects are over-reported and that Pradaxa does not cause more bleeding than warfarin. RLG a Pradaxa law firm acknowledges that… Read more
Medicare Australia’s national universal health care system is reconsidering Pradaxa coverage on the heels of a November 2012 U.S. Food and Drug Administration medical alert warning against the use of blood thinner on patients with mechanical heart valves according to a FiercePharma article. A report authored by the Pharmaceutical… Read more
The U.S. Food and Drug Administration issued a safety alert December 19 indicating that patients with mechanical prosthetic heart valves should not use the blood thinner Pradaxa the Rottenstein Law Group reports. Pradaxa manufactured by German drugmaker Boehringer is used to prevent stroke or blood clots. However a… Read more
Despite the popularity of German drug manufacturer Boehringer’s Pradaxa blood-thinning medication regulators worldwide have reported hundreds of deaths associated with the drug’s serious side effects according to a Dec. 11 Bloomberg report. German drug manufacturer Boehringer has brought in more than a billion dollars from sales of its blood-thinning drug… Read more
The Rottenstein Law Group which represents clients with claims stemming from the severe adverse side effects of various prescription drugs and complications caused by dangerous medical devices has learned with great disappointment that an article published in JAMA concludes that the U.S. FDA allowed dangerous drugs to be marketed. According… Read more
The Rottenstein Law Group which represents clients with claims stemming from the severe adverse side effects of various prescription drugs and complications caused by dangerous medical devices is cataloging the dangers of the prescription drug Pradaxa in anticipation of representing those harmed in lawsuits against the medicine’s manufacturer. The… Read more